Gene · 7067
Papers1,888
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
321 to 340 of 1,888
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| NAFLD: Mechanisms, Treatments, and Biomarkers. | Biomolecules | 2022 | 35740949 | PubTator, text mining | PubMed |
| Effects of Thyroid Hormones on Lipid Metabolism Pathologies in Non-Alcoholic Fatty Liver Disease. | Biomedicines | 2022 | 35740254 | PubTator, text mining | PubMed |
| Thyroid hormone resistance: Mechanisms and therapeutic development. | Mol Cell Endocrinol | 2022 | 35738449 | PubTator, text mining | PubMed |
| Assessment of the CYP1A2 Inhibition-Mediated Drug Interaction Potential for Pinocembrin Using In Silico, In Vitro, and In Vivo Approaches. | ACS Omega | 2022 | 35721953 | PubTator, text mining | PubMed |
| Human rs75776403 polymorphism links differential phenotypic and clinical outcomes to a CLEC18A p.T151M-driven multiomics. | J Biomed Sci | 2022 | 35717171 | PubTator, text mining | PubMed |
| A disease-associated mutation in thyroid hormone receptor α1 causes hearing loss and sensory hair cell patterning defects in mice. | Sci Signal | 2022 | 35700264 | PubTator, text mining | PubMed |
| Transcriptomic Characteristics Associated With Aging in the Thyroid Gland. | Front Nutr | 2022 | 35694164 | PubTator, text mining | PubMed |
| A tEMTing target? Clinical and experimental evidence for epithelial-mesenchymal transition in the progression of cutaneous squamous cell carcinoma (a scoping systematic review). | Discov Oncol | 2022 | 35666359 | PubTator, text mining | PubMed |
| An Extended Prognostic Index of the ISSWM Score Based on Thyroid Complications in Waldenström Macroglobulinemia/Lymphoplasmacytoid Lymphoma. | Front Oncol | 2022 | 35646661 | PubTator, text mining | PubMed |
| Resistance to thyroid hormone in a child with thyroid agenesis: A case report with review of the literature. | Ann Med Surg (Lond) | 2022 | 35638026 | PubTator, text mining | PubMed |
| Targeting Nuclear Receptors in Lung Cancer-Novel Therapeutic Prospects. | Pharmaceuticals (Basel) | 2022 | 35631448 | PubTator, text mining | PubMed |
| Exploring the Activity of Fungal Phenalenone Derivatives as Potential CK2 Inhibitors Using Computational Methods. | J Fungi (Basel) | 2022 | 35628699 | PubTator, text mining | PubMed |
| Nuclear Receptor Coregulators in Hormone-Dependent Cancers. | Cancers (Basel) | 2022 | 35626007 | PubTator, text mining | PubMed |
| Biological Prognostic Value of miR-155 for Survival Outcome in Head and Neck Squamous Cell Carcinomas: Systematic Review, Meta-Analysis and Trial Sequential Analysis. | Biology (Basel) | 2022 | 35625379 | PubTator, text mining | PubMed |
| Insights into the Endocrine Disrupting Activity of Emerging Non-Phthalate Alternate Plasticizers against Thyroid Hormone Receptor: A Structural Perspective. | Toxics | 2022 | 35622676 | PubTator, text mining | PubMed |
| Alpha-Synuclein Targeting Therapeutics for Parkinson's Disease and Related Synucleinopathies. | Front Neurol | 2022 | 35614915 | PubTator, text mining | PubMed |
| The Relationship Between Chinese EFL Learners' Resilience and Academic Motivation. | Front Psychol | 2022 | 35602676 | PubTator, text mining | PubMed |
| Emerging advances in the pharmacologic treatment of nonalcoholic steatohepatitis and related cirrhosis. | Ann Gastroenterol | 2022 | 35599922 | PubTator, text mining | PubMed |
| Proteomic Analysis of the Intestinal Resistance to Thyroid Hormone Mouse Model With Thyroid Hormone Receptor Alpha Mutations. | Front Endocrinol (Lausanne) | 2022 | 35574030 | PubTator, text mining | PubMed |
| The Prognostic Role of miR-31 in Head and Neck Squamous Cell Carcinoma: Systematic Review and Meta-Analysis with Trial Sequential Analysis. | Int J Environ Res Public Health | 2022 | 35564727 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7067/papers?page=17